Robert Kamen

Insider Reports History

Location
Boston, MA
Signature
/s/ Caroline Gammill, as attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Robert Kamen:

Company Role Class Num Shares Value Price $ Report Date Ownership
Jounce Therapeutics, Inc. Director Common Stock 0 $1.85 03 May 2023 Direct
Jounce Therapeutics, Inc. Director Common Stock 0 $1.85 03 May 2023 Indirect
Jounce Therapeutics, Inc. Director Stock Option (Right to Buy) 0 03 May 2023 Direct

Insider Reports Filed by Robert Kamen

Symbol Company Period Transactions Value $ Form Type Role Filing Time
/report/000164045523000110-kamen-robert-2023-05-03 Jounce Therapeutics, Inc. 03 May 2023 8 $0 4 Director 04 May 2023, 07:44
/report/000164045522000072-kamen-robert-2022-06-24 Jounce Therapeutics, Inc. 24 Jun 2022 1 $0 4 Director 28 Jun 2022, 21:06
/report/000164045521000113-kamen-robert-2021-06-18 Jounce Therapeutics, Inc. 18 Jun 2021 1 $0 4 Director 22 Jun 2021, 16:49